BackgroundAlthough increased early detection. diagnosis and treatment have improved the outcome of breast cancer patients. prognosis estimation still poses challenges due to the disease heterogeneity. Accumulating data indicated an evident correlation between tumor immune microenvironment and clinical outcomes. https://oznicoes.shop/product-category/k-boots/